If you're currently exploring medical weight loss options, the treatments available today, including GLP-1 medications like semaglutide and tirzepatide, already offer meaningful, evidence-based results
The key difference lies in their composition and potency
NG28 Type 2 diabetes in adults: management Initial medicines chapter
Arnold SV, Bhatt DL, Barsness GW, Beatty AL, Deedwania PC, Inzucchi SE, et al
This is a meaningful path for eligible patients
GLP-1, however, engages the GLP-1R/ERK1/2/HDAC6 axis to modulate downstream transcriptional activity, it lowers intracellular ROS, reduces Akt and ERK1/2 phosphorylation, restores HDAC6 expression, and thereby alleviates endothelial dysfunction and excessive autophagy (Zummo et al., 2017)